Bioxcel Therapeutics, Inc. · NASDAQ:BTAI

Armistice Capital, LLC's stake in Bioxcel Therapeutics, Inc. fell to 4.99% (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Armistice Capital, LLC's stake in Bioxcel Therapeutics, Inc. fell to 4.99%, 288,131 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
4.99%
Shares
288,131
Intent
Passive
What changed
Fell below 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Armistice Capital, LLC4.99%288,131
Steven Boyd4.99%288,131

Source

View original at SEC

Related